ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo

Sambria_Sales Slick_proof 2-1

•
•
Michael Greenspan
Michael Greenspan

This document describes a topical anesthetic analgesic variety pack called NeuroMed that contains benzocaine, lidocaine, and tetracaine. It offers advantages over compounded BLT products like eliminating legal exposure since each ingredient is OTC, reducing contamination risks through single-use packets, and speeding onset through a proprietary formulation. Compared to compounding BLT options, it avoids risks like drug diversion, cross-contamination, wasted time waiting for action, and cumulative systemic absorption from prolonged use. The variety pack contains three boxes of 25 individually wrapped packets for each ingredient for a total of 250 grams of product and application flexibility.

1 of 2
Download to read offline
Your comprehensive topical pain management solution! 888.246.6601 Sales@SambriaPharma.com www.sambriapharma.com TM TOPICAL ANESTHETIC ANALGESIC VARIETY PACK NeuroMed Compare to compounded BLT products: • Eliminate legal exposure - NeuroMed is a variety package that contains benzocaine (20%), lidocaine (4%) and tetracaine (2%) – each is OTC with no prescription required – all products packaged together for convenience and to allow clinician application flexibility • Eliminate cross contamination risk - Each of the included anesthetic analgesics is packaged in single-use, metered dosed, sanitary packets for precision and reduction in cross contamination risk • Reduce onset wait time - NeuroMed products all include a proprietary formulation designed to improve onset and efficacy – speeding onset and reducing treatment time improves productivity and practice revenue • Reduce systemic absorption risk - Reducing anesthetic analgesic time on skin may reduce the risk of cumulative systemic absorption – in an IRB approved study of the NeuroMed lidocaine product which included 239 human test subjects – no active lidocaine nor its active metabolite MEGx entered the blood in even a single subject after multiple applications in an 8 hour period Compare to compound BLT options: • Drug diversion - Exposure to the consequences of drug diversion – procuring, using and passing a prescription drug ordered for one patient but used on others and supplied to other clinicians is, in fact, illegal drug diversion! • Cross contamination - Using multi-use containers on multiple patients exposes patients to the risk of cross contamination • Wasting time - Time wasted waiting 45 – 60 minutes or more for anesthetic action decreases practice revenue by tying up treatment rooms and clinicians • Cumulative systemic absorption risk Exposing patients to anesthetic on the skin over a prolonged period of time increases risk of cumulative systemic absorption
Product Description The NeuroMed Analgesic Variety Pack is a combination package of three individually wrapped topical, local, anesthetic analgesics – benzocaine, lidocaine and tetracaine. Each individual anesthetic analgesic is provided in its own box and packaged together for the convenience of the clinician. This unique comprehensive variety option has been created to allow clinical flexibility beyond that of other single API topical anesthetic analgesic options Explanation All include the standard Sambria Pharmaceuticals’ proprietary formulation designed to improve delivery and rate of onset of the active pharmaceutical ingredients (API’s) Each type of anesthetic analgesic is packaged separately in individual 3-ml packets (4-ml for lidocaine). Each anesthetic analgesic is packaged in boxes of 25 units per box for a total combined 250 grams of product. All three boxes are wrapped in a single, combination variety package for clinician convenience and application flexibility Cost-effective - competitively priced (MSRP - only $0.80 per gram to clinical customer) 888.246.6601 Sales@SambriaPharma.com www.sambriapharma.com Contact Sambria Pharmaceuticals directly or your local representative. TM Package Contents • 3 boxes each of 25 single-use, sanitary packets per product: • Benzocaine 20% / 25 – 3 ml packet (NeuroMed FA) • Lidocaine 4% / 25 – 4 ml packet (NeuroMed 7) • Tetracaine 2% / 25 – 3 ml packet (NeuroMed LA)

More Related Content

Sambria_Sales Slick_proof 2-1

  • 1. Your comprehensive topical pain management solution! 888.246.6601 Sales@SambriaPharma.com www.sambriapharma.com TM TOPICAL ANESTHETIC ANALGESIC VARIETY PACK NeuroMed Compare to compounded BLT products: • Eliminate legal exposure - NeuroMed is a variety package that contains benzocaine (20%), lidocaine (4%) and tetracaine (2%) – each is OTC with no prescription required – all products packaged together for convenience and to allow clinician application flexibility • Eliminate cross contamination risk - Each of the included anesthetic analgesics is packaged in single-use, metered dosed, sanitary packets for precision and reduction in cross contamination risk • Reduce onset wait time - NeuroMed products all include a proprietary formulation designed to improve onset and efficacy – speeding onset and reducing treatment time improves productivity and practice revenue • Reduce systemic absorption risk - Reducing anesthetic analgesic time on skin may reduce the risk of cumulative systemic absorption – in an IRB approved study of the NeuroMed lidocaine product which included 239 human test subjects – no active lidocaine nor its active metabolite MEGx entered the blood in even a single subject after multiple applications in an 8 hour period Compare to compound BLT options: • Drug diversion - Exposure to the consequences of drug diversion – procuring, using and passing a prescription drug ordered for one patient but used on others and supplied to other clinicians is, in fact, illegal drug diversion! • Cross contamination - Using multi-use containers on multiple patients exposes patients to the risk of cross contamination • Wasting time - Time wasted waiting 45 – 60 minutes or more for anesthetic action decreases practice revenue by tying up treatment rooms and clinicians • Cumulative systemic absorption risk Exposing patients to anesthetic on the skin over a prolonged period of time increases risk of cumulative systemic absorption
  • 2. Product Description The NeuroMed Analgesic Variety Pack is a combination package of three individually wrapped topical, local, anesthetic analgesics – benzocaine, lidocaine and tetracaine. Each individual anesthetic analgesic is provided in its own box and packaged together for the convenience of the clinician. This unique comprehensive variety option has been created to allow clinical flexibility beyond that of other single API topical anesthetic analgesic options Explanation All include the standard Sambria Pharmaceuticals’ proprietary formulation designed to improve delivery and rate of onset of the active pharmaceutical ingredients (API’s) Each type of anesthetic analgesic is packaged separately in individual 3-ml packets (4-ml for lidocaine). Each anesthetic analgesic is packaged in boxes of 25 units per box for a total combined 250 grams of product. All three boxes are wrapped in a single, combination variety package for clinician convenience and application flexibility Cost-effective - competitively priced (MSRP - only $0.80 per gram to clinical customer) 888.246.6601 Sales@SambriaPharma.com www.sambriapharma.com Contact Sambria Pharmaceuticals directly or your local representative. TM Package Contents • 3 boxes each of 25 single-use, sanitary packets per product: • Benzocaine 20% / 25 – 3 ml packet (NeuroMed FA) • Lidocaine 4% / 25 – 4 ml packet (NeuroMed 7) • Tetracaine 2% / 25 – 3 ml packet (NeuroMed LA)